Human Pluripotent Stem Cells to Assess Developmental Toxicity in the Osteogenic Lineage

Area of Science:

• Developmental toxicology
• Stem cell biology
• Skeletal biology

Background:

• Musculoskeletal birth defects are common, but their causes are poorly understood.
• Environmental toxicants are suspected contributors to skeletal malformations.
• Current methods for assessing chemical toxicity are often expensive, time-consuming, and lack human specificity.

Purpose of the Study:

• To develop a human-specific in vitro method for assessing the developmental toxicity of environmental toxicants on osteoblast differentiation.
• To establish a protocol for differentiating human embryonic stem cells into osteoblasts.
• To evaluate the impact of toxicants on osteogenic differentiation and mitochondrial activity.

Main Methods:

• Differentiation of human embryonic stem cells into the osteogenic lineage.
• Assessment of differentiation inhibition under toxicant exposure.
• Evaluation of mitochondrial activity in exposed human embryonic stem cells and fibroblasts.
• Development of a human-specific screening assay for osteogenic developmental toxicity.

Main Results:

• The study provides a detailed protocol for human embryonic stem cell differentiation into osteoblasts.
• Methods are outlined for assessing toxicant-induced inhibition of osteogenic differentiation.
• The protocol integrates mitochondrial activity assays for a comprehensive toxicity evaluation.
• This approach enables human-specific screening of developmental toxicity impacting the osteogenic lineage.

Conclusions:

• A human-specific in vitro method using embryonic stem cells can effectively screen for developmental toxicants affecting bone formation.
• This protocol offers a valuable alternative to animal testing for assessing skeletal malformation risks.
• The findings contribute to a better understanding of the etiology of musculoskeletal birth defects.